title: cAMP and calcium ionophore induce outgrowth of neuronal processes in PC12 mutant cells in which nerve growth factor-induced outgrowth of neuronal processes is impaired.
abstract: During continuous culturing, PC12 cells are subject to spontaneous mutations. We obtained PC12m3 cells, clone cells in which outgrowth of neuronal processes (dendrites and axons) under the condition of nerve growth factor (NGF) treatment was highly stimulated by various inducers, such as cyclic adenosine monophosphate (cAMP), calcium ionophore, steroid and high osmolarity. The number of cells with neuronal processes in the presence of cAMP was approximately twenty-fold greater than PC12 parental cells and other PC12 mutant cells. In PC12m3 cells, NGF-induced outgrowth of neuronal processes was reduced by cytotoxic solanine, whereas the effect of NGF was unaffected by hyaluronic acid. In PC12m3 cells, various inducers of neurite outgrowth, such as cAMP, calcium ionophore and high osmolarity, activated mitogen activated protein (MAP) kinase, whereas solanine and hyaluronic acid did not cause any significant activation of MAP kinase. However, PC12m3 cells, in which NGF-induced outgrowth of neuronal processes were impaired, had strong NGF-induced MAP kinase activity as PC12 parental cells had. These findings suggest that cAMP, calcium influx and high osmolarity induce outgrowth of neuronal processes in PC12m3 cells through activation of the downstream target of MAP kinase or through a novel pathway independent of NGF activation.
authors: Department of Health Science, Kibi International University, Takahashi, Okayama 716-8508, Japan. yoshio@kiui.ac.jp
authors: Y
authors: Y
authors: Kano
authors: T
authors: T
authors: Nohno
authors: R
authors: R
authors: Takahashi
authors: T
authors: T
authors: Hasegawa
authors: F
authors: F
authors: Hiragami
authors: K
authors: K
authors: Kawamura
authors: H
authors: H
authors: Motoda
authors: T
authors: T
authors: Sugiyama
mesh_terms: D000818:Animals; D001369:Axons / Q000187:drug effects* / Q000502:physiology; D000001:Calcimycin / Q000494:pharmacology*; D002135:Calcium-Binding Proteins / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology*; D003712:Dendrites / Q000187:drug effects* / Q000502:physiology; D019950:Mitogen-Activated Protein Kinase 1 / Q000187:drug effects / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases / Q000187:drug effects / Q000378:metabolism; D020932:Nerve Growth Factor / Q000494:pharmacology*; D009994:Osmolar Concentration; D016716:PC12 Cells / Q000187:drug effects; D051381:Rats
chemical_list: D002135:Calcium-Binding Proteins; C025673:calciphorin; D000001:Calcimycin; D020932:Nerve Growth Factor; D000242:Cyclic AMP; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases